[
  {
    "ts": "2025-06-26T21:47:41+00:00",
    "headline": "Zimmer Biomet’s Q1 Earnings Call: Our Top 5 Analyst Questions",
    "summary": "Zimmer Biomet’s first quarter results were met with a sharp negative reaction from the market, as investors weighed both the modest revenue growth and a lowered outlook for the year. Management attributed the quarter’s performance to strong adoption of new hip products in the U.S. and sustained mid-single-digit growth in its S.E.T. (Sports Medicine, Extremities and Trauma) segment, despite facing a headwind from one less selling day. CEO Ivan Tornos highlighted the impact of Zimmer Biomet’s \"mag",
    "url": "https://finance.yahoo.com/news/zimmer-biomet-q1-earnings-call-214741324.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "e6d6a7e2-70d7-3a52-9cbc-3fe125c0f794",
      "content": {
        "id": "e6d6a7e2-70d7-3a52-9cbc-3fe125c0f794",
        "contentType": "STORY",
        "title": "Zimmer Biomet’s Q1 Earnings Call: Our Top 5 Analyst Questions",
        "description": "",
        "summary": "Zimmer Biomet’s first quarter results were met with a sharp negative reaction from the market, as investors weighed both the modest revenue growth and a lowered outlook for the year. Management attributed the quarter’s performance to strong adoption of new hip products in the U.S. and sustained mid-single-digit growth in its S.E.T. (Sports Medicine, Extremities and Trauma) segment, despite facing a headwind from one less selling day. CEO Ivan Tornos highlighted the impact of Zimmer Biomet’s \"mag",
        "pubDate": "2025-06-26T21:47:41Z",
        "displayTime": "2025-06-26T21:47:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/6edde082034a9d932281221482f4ebed",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ZBH Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GeR3T5vTqnjo7Gx.oPgKjw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/6edde082034a9d932281221482f4ebed.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QfijZY2TGZIuX4ND2T.vmw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/6edde082034a9d932281221482f4ebed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zimmer-biomet-q1-earnings-call-214741324.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zimmer-biomet-q1-earnings-call-214741324.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZBH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]